- Home
- FGF vs NAII Comparison
FGF vs NAII Comparison
Compare FGF & NAII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGF
- NAII
- Stock Information
- Founded
- FGF 2012
- NAII 1980
- Country
- FGF United States
- NAII United States
- Employees
- FGF N/A
- NAII N/A
- Industry
- FGF Property-Casualty Insurers
- NAII Medicinal Chemicals and Botanical Products
- Sector
- FGF Finance
- NAII Health Care
- Exchange
- FGF Nasdaq
- NAII Nasdaq
- Market Cap
- FGF 22.8M
- NAII 23.7M
- IPO Year
- FGF N/A
- NAII 1987
- Fundamental
- Price
- FGF $16.00
- NAII $2.78
- Analyst Decision
- FGF
- NAII
- Analyst Count
- FGF 0
- NAII 0
- Target Price
- FGF N/A
- NAII N/A
- AVG Volume (30 Days)
- FGF 2.6K
- NAII 10.6K
- Earning Date
- FGF 05-19-2025
- NAII 05-13-2025
- Dividend Yield
- FGF N/A
- NAII N/A
- EPS Growth
- FGF N/A
- NAII N/A
- EPS
- FGF N/A
- NAII N/A
- Revenue
- FGF $17,348,000.00
- NAII $121,853,000.00
- Revenue This Year
- FGF N/A
- NAII N/A
- Revenue Next Year
- FGF N/A
- NAII N/A
- P/E Ratio
- FGF N/A
- NAII N/A
- Revenue Growth
- FGF 1.49
- NAII N/A
- 52 Week Low
- FGF $14.21
- NAII $2.77
- 52 Week High
- FGF $38.40
- NAII $7.26
- Technical
- Relative Strength Index (RSI)
- FGF 35.81
- NAII 32.43
- Support Level
- FGF $15.51
- NAII $2.84
- Resistance Level
- FGF $18.35
- NAII $3.34
- Average True Range (ATR)
- FGF 0.70
- NAII 0.28
- MACD
- FGF -0.11
- NAII -0.03
- Stochastic Oscillator
- FGF 13.10
- NAII 8.70
About FGF FG Financial Group Inc. (NV)
Fundamental Global Inc through its subsidiaries operates as diversified insurance, reinsurance, and investment management holding company. The company's segment includes Insurance and Asset Management. It generates maximum revenue from the Insurance segment.
About NAII Natural Alternatives International Inc.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.